Shiota C, Takeuchi K*, Kusama K, Tamada U, Oda F, Maeda M, Osaka K, Fukuda H.
Impact of no cost-sharing for public assistance recipients on health service usage in Japan.
JAMA Health Forum 2025; 6(10): e253713.
Kawaguchi K, Maeda M, Murata F, Endo M, Nakashima Y, Fukuda H*.
Incidence and temporal trends of depression and anxiety following cancer diagnosis in Japan: Insights from the LIFE Study.
International Journal of Cancer 2025; in press.
Maeda M, Murata F, Fukuda H*.
Effects of the introduction of a routine rotavirus vaccination program on vaccination coverage and factors in a Japanese municipality: The VENUS Study.
BMJ Public Health 2025; 3: e002149.
Murata F, Maeda M, Fukuda H*.
Evaluation of Salt Intake Levels and Related Factors in Individuals Who Underwent a Specific Health Examination: LIFE Study.
JMA Journal 2025:8(4): 1214-1219.
Honda K, Goto K*, Maeda M, Murata F, Fukuda H.
Association between Antihypertensive Treatment Discontinuation and the Development of Intracerebral Hemorrhage in Japanese Hypertensive Patients: The LIFE Study.
Journal of the American Heart Association 2025; 14: e042523.
Sagara K, Goto K*, Maeda M, Fukuda H.
Associations Between Cardiovascular Health Metrics in Life’s Essential 8 and Incident Hypertension: The LIFE Study.
Journal of Human Hypertension 2025; 39(10): 716-722
Kinugawa A, Takeuchi K, Tamada Y, Kusama T, Sato M, Maeda M, Murata F, Osaka K, Fukuda H.
Differences in healthcare expenditure due to the comorbidity status of periodontal disease and diabetes mellitus: A retrospective cohort study from the LIFE Study.
Journal of Periodontology2025; 96: 760–768
Komatsu M*, Ge S, Kimura Y, Zha L, Narii N, Okita Y, Shimomura Y, Gon Y, Murata F, Maeda M, Komukai S, Kiyohara K, Kitamura T, Mochizuki H, Fukuda H.
Functional outcomes in older patients after Parkinson’s disease diagnosis in Japan: The LIFE study.
Clinical Parkinsonism & Related Disorders 2025; 13: 100375.
Matsumoto K, Maeda M, Matsuo R, Fukuda H, Ago T, Kitazono T, Kamouchi M, Irie F*.
Association between procedure volume and 30-day mortality in stroke patients treated with EVT or IV rt-PA during the introduction period of EVT in Japan.
Global Health & Medicine 2025: 7(3):233-240.
Akeno Y, Maeda M, Murata F, Fukuda H*.
Metabolic dysfunction-associated fatty liver disease and risks of incident coronary artery disease and cerebrovascular disease: The LIFE Study.
Hepatology Research 2025; 55: 807-817.